Advertisement

Topics

Latest "DeCODE Genetics Inc & ARUP Laboratories" News Stories

10:59 EDT 23rd May 2018 | BioPortfolio

Here are the most relevant search results for "DeCODE Genetics Inc & ARUP Laboratories" found in our extensive news archives from over 250 global news sources.

More Information about DeCODE Genetics Inc & ARUP Laboratories on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about DeCODE Genetics Inc & ARUP Laboratories for you to read. Along with our medical data and news we also list DeCODE Genetics Inc & ARUP Laboratories Clinical Trials, which are updated daily. BioPortfolio also has a large database of DeCODE Genetics Inc & ARUP Laboratories Companies for you to search.

Showing "DeCODE Genetics ARUP Laboratories" News Articles 1–25 of 3,300+

Wednesday 23rd May 2018

BioGENEius Challenge 2018 BioSTEM Leader Awardee

Today, the Biotechnology Institute announced the winner of the BioSTEM Leader Award, who will be recognized next week at the 2018 Biotechnology Industry Organization Annual Convention (BIO 2018) in Boston. We would not have the quality of national excellence at the BioGENEius Challenge or the talent to feed our future biotechnology workforce were ...


Gene Synthesis Services Market - Increasing Focus on Product and Service Innovation Boosts Growth | Technavio

Technavio market research analysts forecast the global gene synthesis services market to grow at a C

Institut Curie Names Intel Lead Partner to Implement High-Performance Computing and Artificial Intelligence in Accelerating Genome Sequencing and Interpretation for Oncology

Institut Curie and Intel initiate a pioneering collaboration to develop, use and implement innovative bioinformatics tools, pipelines and techniques to improve the use of molecular profiling across both research and clinical oncology settings. Precision medicine for cancer requires the delivery of individually adapted medical care based on the gen...


Major Cancer Center Further Advances Oncology Research by Integrating Genomic Data Into Medidata's eClinical Platform

Pancreatic Cancer Research Exemplifies Increasing Use of Genomic Data for Precision Medicine Medidata (NASDAQ: MDSO) announced that Memorial Sloan Kettering Cancer Center (MSK) is using Rave Omics with Biomarker Discovery for patients with pancreatic cancer, an example of the paradigm shift in clinical trials through the systematic capture of genomic d...

Translate Bio Names John R. Schroer, CFA, Chief Financial Officer

Translate Bio, a leading messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced the appointment of John R. Schroer, CFA, as Chief Financial Officer. With 28 years of healthcare investment experience, Mr. Schroer brings expertise in fin...

LogicBio Therapeutics Appoints Dean Falb, Ph.D., as Chief Scientific Officer

Genome editing company adds drug development expert in pursuit of breakthrough medicines for pediatric patients LogicBio Therapeutics, Inc., a genetic medicine company founded to develop safe and lasting treatments for children with life-threatening early onset diseases, today announced the a

Kraig Biocraft Laboratories Develops New Breakthrough Spider Silk DNA Synthesis Protocols Accelerating Time to Market for New Products

Kraig Labs’ R&D team raises the bar in transgenic research Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that its R&D team has achieved a major breakthrough in the construction of DNA encoding for spider silk proteins. With this new capability the C...

New Thermo Scientific Prisma SEM Combines Performance and Versatility

New Prisma has the simplicity and speed required for industrial applications and the advanced capabilities needed for research. Scientists working in industrial and academic R&D, quality control, and failure analysis laboratories now have access to a simple but powerful new scanning electron microscope (SEM) that also offers a full range of imaging and analytical options....

CENTOGENE Announces Drug Development Collaboration with Orphazyme in Neuronopathic Gaucher Disease

CENTOGENE’s Deep Expertise in Biomarker Identification to Help Guide Clinical Trials CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced a clinical development collaboration with Orphazyme A/S (CPH: ORPHA) to improve the lives of patients and famil...

Tuesday 22nd May 2018

Advanced genetics study of TB bacteria uncovers virulent 'Beijing lineage' strain among young adults

LSTM's Dr Maxine Caws is co-lead investigator on an advanced genetics study published in Nature Genetics(link is external), which has shown that a virulent strain of tuberculosis (TB) has adapted to transmit among young adults in Ho Chi Minh City, Vietnam.

Genetics Home Reference: spinal muscular atrophy with lower extremity predominance

Source: National Library of Medicine - Related MedlinePlus Pages: Spinal Muscular Atrophy

MyoGen: Leaders of an Anabolic Revolution

GUJARAT, India, May 23, 2018 (GLOBE NEWSWIRE) -- Myogen will make you rethink what the human body is capable of.To be an athlete means to partake on a never-ending quest for self-improvement. An obsession to search for a winning edge. Even when we are competing against ourselves, our desire to overcome our physical limitations and achieve new heroic and record setting performances becomes ...

Rare Disease Report® Expands Strategic Alliance Partnership with Lowe Syndrome Association

The partnership will help enhance the lives of patients and their family through informative initiatives Rare Disease Report® (RDR®), a digital component of Rare Disease Communications®, adds the Lowe Syndrome Association (LSA) to the Strategic Alliance Partnership program, announced Michael J. Hennessy Jr., president of MJH Associates, Inc., parent...

Patterson Companies Named to Fortune 500 List for Second Consecutive Year

Patterson Companies (Nasdaq: PDCO) today announced that it has been named to the Fortune 500 list of America’s largest companies for the second year in a row. In its 64th year, the Fortune 500 ranks U.S. companies by total revenues for their respective fiscal years. Fortune announced the selection of Patterson Companies and other corporations in the com...

A Clinical Trial Wants Your DNA–What Should You Do?

(The Conversation) – On May 6, the “All of Us” study started enrolling participants. This national study will be one of the largest ever examining the connection between genetics, behavior and medical outcomes, with a goal of 1 million or … Read More

Dr Reddy's Labs' sales and profit under pressure in Q4, dividend at 400%

Dr Reddy's Laboratories (DRL), a Rs. 14,200 crore plus pharma major, has suffered another setback during the fourth quarter ended March 2018 on account of stagnant sales, significant higher tax provisions, price erosion

India's Dr. Reddy's Q4 profit falls about 19 pct, misses estimates

Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted an about 19 percent fall in quarterly net profit, missing estimates, hurt by headwinds in the U.S. market. Profit for the quarter ended March 31 came in at 2.72 billion rupees versus 3.38 billion rupees a year earlier, the company said here Net sales fell slightly to 34.46 billion rupees.

Oxford Immunotec Announces Launch of the Accutix(TM) Brand

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 22, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced the launch of the Accutix brand for its tick-borne disease offering. "Incorporating the feedback of our customers was a key consideration in our selection of a new brand name," said Dr. Peter Wrighton-S...

Dr. Reddy's Laboratories Limited 2018 Q4 - Results - Earnings Call Slides

Innovative New Method Tracks Drug, Gene Deliver to Cells

NewsResearchers say they know how to track and map drug and gene delivery vehicles to evaluate which are most effective at infiltrating cells and getting to their targets, insight that could guide development of new pharmaceutical agents.

Dr. Reddy’s Q4 and FY18 Financial Results

Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the fourth quarter and full year ended March 31, 2018 under International Financial Reporting Standards (IFRS). Q4 Performance Summary   ...

BioGenerator and Kingdom Capital Lead $2.4 Million Series A Venture Capital Financing for Canopy Biosciences

Startup to Advance Research Tools Development and Add Jobs Canopy Biosciences has exceeded its Series A financing goal, closing a $2.4 million investment to develop new research tools, commercialize its cutting-edge products, and hire additional employees. BioGenerator, the investment arm of BioSTL, and Kingdom Capital co-led the multi-million-dollar d...

Zoetis to Participate in the Stifel 2018 Dental & Veterinary Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2018 Dental & Veterinary Conference on Wednesday, May 30, 2018, in New York, N.Y. Kristin Peck, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, will represent the company and respond to questions from analysts. She is scheduled to present at 1...

Asuragen to Launch the AmplideX® PCR/CE DMPK Kit and Present Growing Genetic Testing Portfolio at 2018 European Society of Human Genetics (ESHG) Conference

The AmplideX DMPK Kit is the first of several new genetics products in 2018 Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy to use products for complex testing in genetics and oncology, today announced the launch of the AmplideX® PCR/CE DMPK Kit* to simplify analysis of repeat

New data changes the way scientists explain how cancer tumours develop

A collaborative research team has uncovered new information that more accurately explains how cancerous tumours grow within the body. This study is currently available in Nature Genetics. Researchers led by scientists at The University of Texas Medical...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks